Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diarylamide compound and application thereof

A compound, formamide technology, applied in the field of diuretics, can solve the problem of no increase in urine osmotic pressure

Active Publication Date: 2020-12-22
SUNSHINE LAKE PHARM CO LTD
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And after 5 days of strictly controlled fluid intake, their urine osmolality did not increase

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diarylamide compound and application thereof
  • Diarylamide compound and application thereof
  • Diarylamide compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0219] Example 1 N-(4-acetylaminophenyl)-4-nitrobenzamide

[0220]

[0221] Suspend p-nitrobenzoic acid (3-1a, 167mg, 1mmol) in dichloromethane (5mL), add 2 drops of DMF, and cool to 0°C in an ice-water bath. Oxalyl chloride (190mg, 0.13mL, 1.5mmol) was slowly added dropwise, and the mixture was stirred at room temperature for 2 hours. The reaction solution was concentrated to remove the solvent and excess oxalyl chloride to obtain p-nitrobenzoyl chloride (3-2a), which was added to tetrahydrofuran (1 mL) for later use without further purification. Paracetaminoaniline (3-3a, 150 mg, 1 mmol) was dissolved in tetrahydrofuran (5 mL), triethylamine (152 mg, 1.5 mmol) was added, and the tetrahydrofuran solution of the above acid chloride 3-2a was added dropwise under ice bath. After dropping, react at room temperature to TLC (CH 2 Cl 2 :MeOH=15:1) showed that the reaction was complete. Add 30 mL of water to the reaction system, continue to stir for 10 minutes and then filter ...

Embodiment 2

[0223] Example 2 N-(4-acetylphenyl)-5-nitrofuran-2-carboxamide

[0224]

[0225] Synthetic method is the same as embodiment 1. Yellow solid, yield 81%, melting point 233-234°C.

[0226] 1 H NMR (400MHz, DMSO-d 6 )δ10.91(s,1H),7.99(d,J=8.0Hz,2H),7.90(d,J=8.0Hz,2H),7.82(d,J=2.4Hz,1H),7.69(d, J=2.4Hz,1H),2.55(s,3H); 13 C NMR (101MHz, DMSO-d 6 )δ197.13, 155.33, 152.36, 147.92, 142.68, 133.14, 129.84, 120.31, 117.57, 113.90, 26.98.

Embodiment 3

[0227] Example 3 N-(4-acetylaminophenyl)-5-nitrofuran-2-carboxamide

[0228]

[0229] Synthetic method is the same as embodiment 1. Orange solid, yield 80%, melting point 233-234°C.

[0230] 1 H NMR (400MHz, DMSO-d 6 )δ10.59(s,1H),9.97(s,1H),7.81(d,J=4.0Hz,1H),7.62-7.66(m,3H),7.57(d,J=8.8Hz,2H), 2.04(s,3H); 13 C NMR (101MHz, DMSO-d 6 )δ168.61, 154.79, 152.20, 148.56, 136.49, 133.32, 121.66, 119.71, 116.77, 113.97, 24.40. HRMS m / z: calcd for C 16 h 13 N 3 o 4 ,([M+H]+):285.08698,Found:285.08696.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Login to View More

Abstract

The invention discloses a use of a diarylamide compound with a structure shown as a formula (I), and a pharmaceutically acceptable salt thereof in the preparation of a medicine serving as a urea transporter inhibitor, and the novel diarylamide compound. The diarylamide compound has good urea transporter inhibitor effects, can generate urea selective diuresis in vivo, and has no obvious toxic effects.

Description

technical field [0001] The invention relates to the field of diuretics, in particular to diarylamide compounds, their pharmaceutically acceptable salts and their use in the preparation of drugs as urea channel protein inhibitors. Background technique [0002] 1. Current applications and research and development hotspots of diuretics [0003] Diuretics act on the kidneys to increase water excretion. Clinically, it is mainly used to treat edema caused by various reasons, and it can also be used to treat some non-edematous diseases. For example, as a first-line drug, it can be used alone or in combination with other drugs to treat hypertension, reduce the incidence of cardiovascular and cerebrovascular diseases and mortality Rate. Diuretics can be divided into potassium-sparing diuretics, thiazide diuretics, loop diuretics, and carbonic anhydrase inhibitors according to their different sites of action. Potassium-sparing diuretics represented by amiloride and triamterene main...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/167A61K31/341A61K31/381A61K31/40A61K31/421A61K31/443A61K31/497A61K31/506A61K31/501A61K31/4709A61K31/427A61K31/422A61K31/4155A61K31/5377A61K31/496A61P7/10A61P9/00A61P13/12A61P9/04A61P35/00A61P1/16A61P1/00A61P9/12A61P37/08C07C231/02C07C233/80C07D307/71C07D307/68C07D333/38C07D207/34C07D263/34C07D333/44C07D405/12C07D409/12C07D417/12C07D413/12
CPCA61K31/167A61K31/341A61K31/381A61K31/40A61K31/421A61K31/443A61K31/497A61K31/506A61K31/501A61K31/4709A61K31/427A61K31/422A61K31/4155A61K31/5377A61K31/496A61P7/10A61P9/00A61P13/12A61P9/04A61P35/00A61P1/16A61P1/00A61P9/12A61P37/08C07C231/02C07C233/80C07D307/71C07D307/68C07D333/38C07D207/34C07D263/34C07D333/44C07D405/12C07D409/12C07D417/12C07D413/12A61P13/00C07D307/72
Inventor 杨宝学李润涛李敏张顺赵岩
Owner SUNSHINE LAKE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com